Five-year results of a treatment program for chronic hepatitis B in Ethiopia

[1]  S. Vento,et al.  Chronic liver diseases must be reduced worldwide: it is time to act. , 2022, The Lancet. Global health.

[2]  M. Sonderup,et al.  Global Disparities in Hepatitis B Elimination—A Focus on Africa , 2022, Viruses.

[3]  M. Manns,et al.  Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection , 2019, Liver international : official journal of the International Association for the Study of the Liver.

[4]  N. Berhe,et al.  The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia. , 2019, Journal of hepatology.

[5]  Q. Ning,et al.  Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results , 2019, Hepatology International.

[6]  N. Berhe,et al.  Treatment of chronic hepatitis B in sub-Saharan Africa: 1-year results of a pilot program in Ethiopia , 2018, BMC Medicine.

[7]  D. Jun,et al.  Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis , 2018, World journal of gastroenterology.

[8]  S. Alavian,et al.  Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. , 2018, The lancet. Gastroenterology & hepatology.

[9]  C. Trautwein,et al.  Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany , 2016, Digestive Diseases and Sciences.

[10]  T. Therneau,et al.  Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B , 2015, Cancer.

[11]  P. Siersema,et al.  Real life adherence of chronic hepatitis B patients to entecavir treatment. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[12]  G. Cooke,et al.  The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa , 2015, Gut.

[13]  M. Buti,et al.  Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection , 2014, Digestive Diseases and Sciences.

[14]  P. Marcellin,et al.  Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load , 2013, Hepatology.

[15]  John F. Flaherty,et al.  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study , 2013, The Lancet.

[16]  Jun Yong Park,et al.  Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis , 2012, PloS one.

[17]  S. Biadgilign,et al.  Predictors of adherence to antiretroviral therapy among people living with HIV/AIDS in resource-limited setting of southwest ethiopia , 2010, AIDS research and therapy.

[18]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[19]  Oliver N Keene,et al.  Lamivudine for patients with chronic hepatitis B and advanced liver disease. , 2004, The New England journal of medicine.

[20]  W. Alexander,et al.  European Association for the Study of the Liver , 1968 .

[21]  M. Fathalla,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[22]  Riccardo Lencioni,et al.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. , 2012, Journal of hepatology.

[23]  EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.

[24]  A. Lok,et al.  Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. , 2011, Journal of hepatology.

[25]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2000, The Journal of the American College of Dentists.

[26]  B. Koblin,et al.  Hepatitis B virus infection. , 1998, The New England journal of medicine.